| Literature DB >> 36193296 |
Tao Zeng1, MingSheng Wang1, Zijun Xu2, Min Ni3, Liang Gao1.
Abstract
Objective: The multidrug-resistant (MDR) gram-negative bacteria-induced intracranial infections after neurosurgical procedures represent a particular therapeutic challenge. Combining the removal of infected prosthetic meninge plus an appropriate antibiotic administration appears to be the only therapeutic strategy likely to succeed when the infection is complicated by artificial dura mater. This study aimed to assess the efficacy of free fascia lata as a substitute for dura reconstruction in the salvage treatment for such recalcitrant nosocomial infections.Entities:
Keywords: duraplasty; fascia lata; gram-negative bacteria; intracranial infection; multidrug-resistant; surgical site infection
Year: 2022 PMID: 36193296 PMCID: PMC9526421 DOI: 10.2147/IDR.S381087
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.177
Clinical Data, Treatment and Outcome of 19 Patients
| Case | Gender/Age | Underlying Condition | Neurosurgical Site Infection | GCS | SOFA | Interval (d) | Pathogen/Resistance Type | Adjunctive | Regional Antiboitics | Antimirobial Outcome | Subsequent Surgery | GOS at Discharge | Follow-Up(Month) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | f/48 | Supra/BT | SCA+EMP+MEN | 9 | 6 | 7 | Klebsiella Pneumoniae/MDR | Lumbar drainage | ITH /Coli | Cured | CP | 5 | 41 |
| 2 | m/48 | Supra/ICH | SCA+EMP+MEN+VEN+ABS | 8 | 5 | 65 | Acinetobacter baumannii/MDR | New EVD lavage | IVT/ Coli | Cured | VPS | 2 | 23 |
| 3 | m/32 | Supra/TBI | SCA+EMP+MEN+ABS | 6 | 6 | 310 | Klebsiella pneumoniae/XDR | EVD | ITH/Coli | Die/MSOF | |||
| 4 | f/52 | Supra/TBI | SCA+EMP+MEN+VEN+ABS | 5 | 6 | 40 | Acinetobacter baumannii/MDR | New EVD lavage | IVT/ Coli | Cured | VPS+CP | 2 | 47 |
| 5 | f/43 | Supra/TBI | SCA+EMP+MEN | 6 | 6 | 83 | Klebsiella pneumoniae/MDR | New EVD | IVT/ Coli | Cured | VPS | 3 | 51 |
| 6 | m/58 | Supra/TBI | SCA+EMP+MEN+VEN+ABS | 8 | 5 | 53 | Klebsiella pneumoniae/XDR | New EVD lavage | IVT/ Coli | Cured | CP | 3 | 21 |
| 7 | f/43 | Supra/TBI | SCA+VEN+ABS | 8 | 5 | 61 | Acinetobacter baumannii/MDR | New EVD | IVT/ Coli | Cured | VPS | 2 | 27 |
| 8 | f/71 | Infra/TBI | SCA+MEN | 6 | 4 | 46 | Acinetobacter baumannii/MDR | New EVD | IVT/ Coli | Cured | VPS | 2 | 21 |
| 9 | m/60 | Supra/TBI | SCA+EMP | 7 | 7 | 66 | Klebsiella pneumoniae/MDR | Lumbar drainage | Cured | C | 4 | 18 | |
| 10 | m/56 | Supra/TBI | SCA+EMP+MEN+ABS | 5 | 7 | 82 | Acinetobacter baumannii/MDR | Lumbar drainage | IVT/ Coli | Cured | CP | 2 | 52 |
| 11 | m/68 | Supra/TBI | SCA+EMP+MEN+VEN | 6 | 7 | 47 | Klebsiella pneumoniae/MDR | New EVD lavage | IVT/ Coli | Die /ICH | |||
| 12 | m/49 | Supra/TBI | SCA+EMP+MEN+ ABS + VEN | 5 | 8 | 37 | Acinetobacter baumannii/XDR | New EVD | IVT/ Coli | Cured | LPS+CP | 2 | 16 |
| 13 | m/23 | Supra/TBI | SCA+EMP+MEN+ ABS + VEN | 6 | 7 | 25 | Stenotrophomonas maltophilia/MDR | New EVD lavage | IVT/Tig | Cured | LPS | 3 | 33 |
| 14 | m/55 | Infra/ICH | MEN+VEN | 8 | 1 | 32 | Acinetobacter baumannii/MDR | Lumbar drainage | IVT/ Coli | Cured | CP | 3 | 19 |
| 15 | f/51 | Supra/BT | SCA+OST+EMP | 15 | 1 | 22 | Klebsiella pneumoniae/MDR | Cured | 3 | 21 | |||
| 16 | m56 | Infra/CM | SCA+OST+MEN+VEN | 10 | 2 | 19 | Klebsiella pneumoniae/MDR | Lumbar drainage Ommya | ITH/ Coli IVT/Coli | Cured | VPS | 4 | 26 |
| 17 | m/38 | Infra/BT | Repeated MEN | 15 | 1 | 91 | Pseudomonas aeruginosa/XDR | Lumbar drainage | ITH/Amik | Cured | 5 | 44 | |
| 18 | m/42 | Supra/BT | SCA+OST+EMP | 15 | 1 | 22 | Pseudomonas aeruginosa/MDR | Cured | 5 | 13 | |||
| 19 | m/41 | Infra/ICH | SCA+EMP+MEN+VEN+ABS | 7 | 6 | 34 | Acinetobacter baumannii/XDR | New EVD lavage | IVT/Coli | Cured | VPS | die/brain stem hemorrhage | |
Abbreviations: supra, supratentorial; infra, infratentorial; BT, brain tumor; TBI, traumatic brain injury; ICH, intracerebral hemorrhage; interval, time interval from establishment of SSIs to debridement surgery; VPS, ventricular peritoneal shunt; LPS, lumbar peritoneal shunt; lavage, ventricular lavage; SCA, scalp infection; emp, empyema; OST, osteotitis; ABS, abscess; Men, menigitis; Ven, ventriculartitis; Coli, colistin; Tig, Tigecycline; Amik, Amikacin; ITH, intrathecal; IVT, intraventricular.
Antimicrobial Susceptibility of Gram-Negative Pathogens
| Pseudomonas aeruginosa (N = 2) | Stenotrophomonas maltophilia (N = 1) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | S | I | R | n | S | I | R | n | S | I | R | n | S | I | R | |
| Piperacillin Tazobactam | 5(100.0%) | 1(12.5%) | 7(87.5%) | 2(100.0%) | ||||||||||||
| Cefazolin | 8(100.0%) | 1 | 7(100.0%) | 2(100.0%) | ||||||||||||
| Cefuroxime | 5 | 3(100.0%) | 4 | 4(100.0%) | ||||||||||||
| Ceftriaxone | 8(100.0%) | 8(100.0%) | c | |||||||||||||
| Ceftazidime | 8(100.0%) | 1(12.5%) | 7(87.5%) | 2(100.0%) | 1 | 1(100.0%) | ||||||||||
| Cefepime | 1 | 7(100.0%) | 1(12.5%) | 7(87.5%) | 2(100.0%) | |||||||||||
| Cefuroxim | 2 | 6(100.0%) | ||||||||||||||
| Cefoperazone Sulbactam | 1(12.5%) | 3(37.5%) | 4(50.0%) | 1 | 1(14.3%) | 1(14.3%) | 5(71.4%) | 2(100.0%) | 1 | 1(100.0%) | ||||||
| Aztreonam | 1(12.5%) | 7(87.5%) | 1(50.0%) | 1(50.0%) | ||||||||||||
| Amikacin | 1 | 1(14.3%) | 6(85.7%) | 4(50.0%) | 4(50.0%) | 1(50.0%) | 1(50.0%) | |||||||||
| Tobramycin | 1 | 1(14.3%) | 6(85.7%) | 3(37.5%) | 5(62.5%) | 1(50.0%) | 1(50.0%) | |||||||||
| Ciprofloxacin | 1 | 7(100.0%) | 2(25.0%) | 6(75.0%) | 2(100.0%) | |||||||||||
| Levofloxacin | 1(16.7%) | 1(16.7%) | 4(66.7%) | 2(25.0%) | 6(75.0%) | 2(100.0%) | 1 | 1(100.0%) | ||||||||
| Compound Sulfamethoxazole | 1 | 1(14.3%) | 6(85.7%) | 5(62.5%) | 3(37.5%) | 1(100.0%) | ||||||||||
| Meropenem | 1 | 7(100.0%) | 1 | 1(14.3%) | 6(85.7%) | 2(100.0%) | ||||||||||
| Imipenem | 1 | 7(100.0%) | 1 | 2(28.6%) | 5(71.4%) | 2 | 2(100.0%) | |||||||||
| Minocycline | 2 | 3(50.0%) | 3(50.0%) | 1 | 3(42.9%) | 4(57.1%) | 1 | |||||||||
| Collstin | 1 | 7(100.0%) | 8(100.0%) | 1 | 1(100.0%) | |||||||||||
| Tigecycline | 2 | 4(66.7%) | 2(33.3%) | 1 | 7(100.0%) | |||||||||||
Abbreviations: S, sensitive; I, intermediary; R, resistant; n, not done.
Figure 1Case 1 (A) Preoperative photograph showing a large scalp defect, with a piece of bovine pericardium graft and cortex exposed. (B) Preoperative CT image showing cerebrum mildly bulge outward the bone window. (C) Photograph showing a linear incision on the anterolateral thigh to harvest free fascia lata. (D) A large piece of free fascia lata was harvested, preparing for dura repair. (E) Intraoperative photograph showing a lot of pus on the surface of cortex when the alien dura was removed. (F) Intraoperative photograph showing dural defect was completely repaired in tension-reduced fashion. (G) The incision was closed after extensive subgaleal dissection. (H) The incision healed uneventfully 1 month after the debridement surgery..
Figure 2Case 2 (A) Preoperative photograph showing the broken incision with purulent discharge and CSF leakage. (B) Preoperative photograph showing purulent fluid aspired from the subgaleal cystic fluid collection by diagnostic puncture with a fine syringe. (C) Preoperative axial MR image showing high signal in cystic fluid collections beneath the scalp, temporal lobe and in the bilateral occipital horn of enlarged bilateral ventricle in DWI sequence. (D) Coronal T1-weighted postcontrast MR image showing multiple cystic lesions with ring-enhancement. The supratentorial ventricles enlarged significantly with linear ependymal enhancement. (E) Intraoperative photograph showing a lot of pus in communication through a piece of Tissudura sheet. (F) Intraoperative photograph showing dural defect was deliberately repaired with fascial lata.